» Articles » PMID: 22346540

Transmissibility and Infection Control Implications of Burkholderia Cepacia in Cystic Fibrosis

Overview
Date 2012 Feb 21
PMID 22346540
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the microbiology and potential virulence factors of Burkholderia cepacia; to discuss the studies that have investigated its mode of transmission among cystic fibrosis patients; and to identify the major risk factors associated with acquisition of this pathogen inside and outside of the hospital environment.

Data Sources: MEDLINE search of the literature published between 1986 and 1997 using the key words/subject words Pseudomonas cepacia, Burkholderia cepacia, cystic fibrosis, infection control and transmissibility, and the bibliography of selected papers.

Data Extraction: Selected studies examining epidemiology, microbiology, virulence factors and mode of transmission of B cepacia in cystic fibrosis.

Data Synthesis And Conclusions: B cepacia is a multidrug-resistant Gram-negative bacillus that has recently been recognized as a major respiratory pathogen in patients with cystic fibrosis. Colonization by this organism can lead to rapid pulmonary deterioration and premature death. Recent studies based on genomic subtyping techniques have suggested that it can be transmitted from person to person. Close social contact and hospitalization have been identified as risk factors for cross-infection. With the implementation of strict infection control policies such as segregation according to colonization status, the rate of new colonization has substantially decreased in most cystic fibrosis treatment centres.

Citing Articles

Characterization of polyhydroxyalkanoate production capacity, composition and weight synthesized by JC-1 from various carbon sources.

Chin J, Samian M, Normi Y Heliyon. 2022; 8(3):e09174.

PMID: 35368536 PMC: 8971576. DOI: 10.1016/j.heliyon.2022.e09174.


Molecular and epidemiological analysis of a Burkholderia cepacia sepsis outbreak from a tertiary care hospital in Bangladesh.

Farzana R, Jones L, Rahman M, Sands K, Portal E, Boostrom I PLoS Negl Trop Dis. 2020; 14(4):e0008200.

PMID: 32271750 PMC: 7173934. DOI: 10.1371/journal.pntd.0008200.


Loss of -Linked Protein Glycosylation in Burkholderia cenocepacia Impairs Biofilm Formation and Siderophore Activity and Alters Transcriptional Regulators.

Oppy C, Jebeli L, Kuba M, Oates C, Strugnell R, Edgington-Mitchell L mSphere. 2019; 4(6).

PMID: 31722994 PMC: 6854043. DOI: 10.1128/mSphere.00660-19.


Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Mainz J, Gerber A, Lorenz M, Michl R, Hentschel J, Nader A Case Rep Infect Dis. 2015; 2015:438517.

PMID: 25866686 PMC: 4381717. DOI: 10.1155/2015/438517.


Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.

George R, Cartier Y, Casson A, Hernandez P Can Respir J. 2006; 13(4):215-8.

PMID: 16779467 PMC: 2683282. DOI: 10.1155/2006/495720.


References
1.
Sun L, Jiang R, Steinbach S, Holmes A, Campanelli C, Forstner J . The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995; 1(7):661-6. DOI: 10.1038/nm0795-661. View

2.
Speert D, Bond M, Woodman R, Curnutte J . Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis. 1994; 170(6):1524-31. DOI: 10.1093/infdis/170.6.1524. View

3.
Mahenthiralingam E, CAMPBELL M, Henry D, Speert D . Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol. 1996; 34(12):2914-20. PMC: 229433. DOI: 10.1128/jcm.34.12.2914-2920.1996. View

4.
Whiteford M, Wilkinson J, McColl J, Conlon F, Michie J, Evans T . Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax. 1995; 50(11):1194-8. PMC: 475093. DOI: 10.1136/thx.50.11.1194. View

5.
Tablan O, Carson L, Cusick L, Bland L, Martone W, Jarvis W . Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol. 1987; 25(3):485-7. PMC: 265959. DOI: 10.1128/jcm.25.3.485-487.1987. View